Form 8-K - Current report:
SEC Accession No. 0000950170-24-046290
Filing Date
2024-04-22
Accepted
2024-04-22 12:54:42
Documents
15
Period of Report
2024-04-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amrn-20240418.htm   iXBRL 8-K 105404
2 EX-3.1 amrn-ex3_1.htm EX-3.1 335818
3 EX-10.2 amrn-ex10_2.htm EX-10.2 6579
4 EX-99.1 amrn-ex99_1.htm EX-99.1 20377
5 GRAPHIC img114078973_0.jpg GRAPHIC 39512
  Complete submission text file 0000950170-24-046290.txt   726949

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT amrn-20240418.xsd EX-101.SCH 34140
19 EXTRACTED XBRL INSTANCE DOCUMENT amrn-20240418_htm.xml XML 5152
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 24860547
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)